P-119 HGCSG 1803: Single-arm phase Ⅱ study evaluating efficacy of oxaliplatin, irinotecan and S-1 combination therapy (OX-IRIS) in metastatic pancreatic cancer as first-line treatment

Autor: Sawada, K., Nakano, S., Kawamoto, Y., Miyagishima, T., Sogabe, S., Kobayashi, Y., Ito, K., Sato, A., Chen, Y., Dazai, M., Harada, K., Yuki, S., Yokota, I., Komatsu, Y.
Zdroj: In Annals of Oncology June 2023 34 Supplement 1:S56-S57
Databáze: ScienceDirect